Marcus Butler

Clinician Investigator, Princess Margaret Cancer Centre

Full Biography

Cancers of Interest

Bladder
Cervical
Esophageal
Gastric
Gynecologic
Ovarian
Pancreatic
Skin

Research Interests and Clinical Approach

Clinical trials research focuses on adoptive immunotherapy for multiple different solid tumor types

Projects at BioCanRx

Phase Ib trial of pembrolizumab administered following adoptive cell therapy- A multiple cohort study; The ACTIVATE (Adoptive Cell Therapy InVigorated to Augment Tumor Eradication) Trial

CLINICAL TRIAL TO TEST THE ONCOLYTIC VACCINE APPROACH IN COMBINATION WITH CHECKPOINT INHIBITOR ANTIBODIES

Recent Articles

Giving melanoma the one-two punch

BioCanRX and Partners Announce Funding for Eight New Projects

Public Forum

Adding muscle to the immune system to fight ovarian cancer